Our data provide evidence suggesting that appropriate LH suppression before ovulation contributes to the optimal clinical outcome for patients with PCOS, such as improved implantation rate, clinical pregnancy rate, and live birth rate. Here, PLOD1 is linked to polycystic ovary syndrome.